This is a narrative-only strategic rebranding filing with no hard financial data or catalyst. Monitor future filings for evidence of revenue model transition from pharmaceutical sales to AI/data services, and for any US market entry updates. The stock's micro-cap status ($12M) means sentiment-driven moves are possible, but no fundamental change is substantiated here.
Price Chart
Executive Summary
POM announced a strategic upgrade to reposition itself as an AI-enabled predictive healthcare infrastructure provider, integrating wearables, AI analytics, physician services, and healthcare payment networks. The press release contains no financial data or concrete milestones, making this a forward-looking narrative filing with limited near-term impact.
Key Facts
- POM announced a strategic upgrade to become a predictive healthcare data and services infrastructure provider.
- The new model integrates wearable technologies, AI, physician services, real-world healthcare data, and healthcare payment networks.
- CEO Zhenyang Shi cited a long-term vision and international expansion (including the US) as strategic priorities.
- No financial figures, revenue data, guidance, partnerships, contracts, or timelines were disclosed in the filing.
- The filing is a press release with forward-looking statements and no material quantitative information.
Financial Impact
No financial impact disclosed. Purely strategic repositioning with no dollar amounts or revenue implications provided.
Risk Factors
- No concrete execution milestones, partnerships, or revenue projections were provided — the upgrade remains aspirational.
- Transition from a traditional online pharmacy model to an AI/data infrastructure model carries significant execution and regulatory risks.
- Potential distraction from current revenue-generating operations without disclosed capital allocation or funding plan.
- Chinese regulatory environment for healthcare data and AI remains uncertain.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-074595 |
| Document: ea0296869-6k_pomdoctor.htm | 0001213900-26-074595 |
| Document: 0001213900-26-074595-index-headers.html | 0001213900-26-074595 |
| Document: 0001213900-26-074595-index.html | 0001213900-26-074595 |
| Document: 0001213900-26-074595.txt | 0001213900-26-074595 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 6-K | $0.5314 $1.13 | ▲ +112.65% | ▲ +112.79% | $1.13 (+112.65%) |
Oct 9, 2026 17d ago | 6-K | $0.6210 $0.5310 | ▲ +14.49% | ▲ +13.00% | $1.13 (−81.96%) |
Sep 30, 2026 26d ago | 6-K | $0.9350 $0.8490 | ▼ −9.20% | ▼ −11.11% | $1.13 (+20.86%) |
Sep 24, 2026 4w ago | 6-K | $0.9700 $0.9200 | ▼ −5.15% | ▼ −4.74% | $1.13 (+16.49%) |
Sep 10, 2026 6w ago | 6-K | $0.7423 $0.8290 | ▲ +11.68% | ▲ +12.18% | $1.13 (+52.23%) |
Aug 27, 2026 8w ago | 6-K | $0.9501 $0.8696 | ▼ −8.47% | ▼ −8.74% | $1.13 (+18.93%) |
Aug 10, 2026 11w ago | 6-K | $1.09 $0.8755 | ▼ −19.68% | ▼ −19.63% | $1.13 (+3.67%) |
Aug 3, 2026 12w ago | 6-K | $0.6880 $1.09 | ▲ +58.43% | ▲ +56.40% | $1.13 (+64.24%) |
Jul 15, 2026 14w ago | 6-K | $1.51 $0.8011 | ▼ −46.95% | ▼ −45.97% | $1.13 (−25.17%) |
Jul 13, 2026 15w ago | 6-K | $1.42 $1.13 | ▼ −20.42% | ▼ −19.64% | $1.13 (−20.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers